Related Experiment Videos
[99mTc-HMDP accumulation in soft tissue tumor]
1Department of Radiology, Shinshu University School of Medicine.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|February 24, 2001
Summary
Bone scintigraphy using technetium-99m hydroxymethylene diphosphonate (99mTc-HMDP) can detect about half of soft tissue tumors. This imaging technique shows positive accumulation in 54% of examined soft tissue tumor cases.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Bone scintigraphy is a diagnostic imaging technique.
- Technetium-99m hydroxymethylene diphosphonate (99mTc-HMDP) is a radiotracer used in bone scintigraphy.
- Soft tissue tumors encompass a diverse range of neoplastic conditions affecting non-osseous tissues.
Observation:
- This study examined 68 cases of soft tissue tumors using 99mTc-HMDP bone scintigraphy.
- Tumor diagnoses included lipomas, liposarcomas, neurinomas, lymphomas, and other rare soft tissue neoplasms.
- Radiographic or histopathologic verification was performed for all cases.
Findings:
- Positive accumulation of 99mTc-HMDP was observed in 37 out of 68 cases (54%).
- Negative accumulation was noted in 31 cases (46%).
- The findings suggest that approximately half of soft tissue tumors exhibit detectable accumulation with 99mTc-HMDP.
Implications:
- 99mTc-HMDP bone scintigraphy may serve as a valuable tool in the diagnostic workup of soft tissue tumors.
- Further research could explore the specific tumor types and characteristics that influence 99mTc-HMDP uptake.
- This imaging modality could potentially aid in differentiating benign from malignant soft tissue lesions.